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LiverDevelopmental mechanisms regulating gene expression and the stable acquisition of cell fate direct
cytodifferentiation during organogenesis. Moreover, it is likely that such mechanisms could be exploited to
repair or regenerate damaged organs. DNA methyltransferases (Dnmts) are enzymes critical for epigenetic
regulation, and are used in concert with histone methylation and acetylation to regulate gene expression and
maintain genomic integrity and chromosome structure. We carried out two forward genetic screens for
regulators of endodermal organ development. In the ﬁrst, we screened for altered morphology of developing
digestive organs, while in the second we screed for the lack of terminally differentiated cell types in the
pancreas and liver. From these screens, we identiﬁed two mutant alleles of zebraﬁsh dnmt1. Both lesions are
predicted to eliminate dnmt1 function; one is a missense mutation in the catalytic domain and the other is a
nonsense mutation that eliminates the catalytic domain. In zebraﬁsh dnmt1 mutants, the pancreas and liver
form normally, but begin to degenerate after 84 h post fertilization (hpf). Acinar cells are nearly abolished
through apoptosis by 100 hpf, though neither DNA replication, nor entry into mitosis is halted in the absence
of detectable Dnmt1. However, endocrine cells and ducts are largely spared. Surprisingly, dnmt1mutants and
dnmt1 morpholino-injected larvae show increased capacity for pancreatic beta cell regeneration in an
inducible model of pancreatic beta cell ablation. Thus, our data suggest that Dnmt1 is dispensable for
pancreatic duct or endocrine cell formation, but not for acinar cell survival. In addition, Dnmt1 may inﬂuence
the differentiation of pancreatic beta cell progenitors or the reprogramming of cells toward the pancreatic
beta cell fate.
© 2009 Elsevier Inc. All rights reserved.Introduction
Organogenesis depends on the precise execution of discrete gene
expression cascades and the acquisition of stable cell identities from
multi-potent progenitors. DNA methylation on cytosine is a heritable
epigeneticmodiﬁcation that is pivotal in regulating the transcriptional
accessibility of the genome (reviewed by Cedar (1988)). Cytosine
methylation is often inversely correlated with gene expression
(reviewed by Robertson and Jones (2000)), and is required for the
transcriptional silencing of imprinted genes and transposons, as well
as the somatic inactivation of sex chromosomes (reviewed by Goll and
Bestor (2005)). This regulation is effectuated in part by methylcyto-
sine binding proteins that recruit chromatinmodifyingmachinery and
restrict transcription via heterochromatin formation (reviewed byrson), didier.stainier@ucsf.edu
l rights reserved.Bird and Wolffe (1999)). Methylation extent is correlated with
differential gene expression among tissue types (Futscher et al.,
2002; Song et al., 2005), and there is increasing evidence that
methylation inﬂuences gene expression during embryogenesis
(Meissner et al., 2008; Nishino et al., 2004; Rai et al., 2006; Sanosaka
et al., 2008; Shemer et al., 1991). These and other studies indicate that
as embryogenesis proceeds, cells accumulate epigenetic marks that
progressively alter developmental potential by regulating chromatin
conﬁguration.
In mammals, cytosine methylation patterns are generated and
maintained by a family of DNA methyltransferases (Dnmts). Dnmt1
contains both a carboxyterminal domain that catalyzes methylation at
CpG dinucleotides, as well as an N-terminal regulatory domain, which
has independent transcriptional repressor activity (Dunican et al.,
2008). Dnmt1 is regarded as a maintenance methyltransferase since it
is targeted to the replication fork during S-phase by Uhrf1 (Bostick et al.,
2007), where it preferentially catalyzes methyl group addition to the
nascent, hemi-methylated DNA strand. Although its preference for
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signiﬁcant capacity for de novo methylation (Okano et al., 1998).
Several genetic studies have shown that Dnmt1 is dispensable in
embryonic stem (ES) cells, but is required for the proliferation and
survival of differentiated cell types (Jackson-Grusby et al., 2001; Lei
et al., 1996; Li et al., 1992). Accordingly, Dnmt1 is required for
embryonic development. Mice lacking Dnmt1 die during early
organogenesis stages, and lack ~90% of cytosine methylation (Lei
et al., 1996; Li et al., 1992; Takebayashi et al., 2007). Reduced Dnmt1
activity in Xenopus (Stancheva et al., 2001) and zebraﬁsh (Martin
et al., 1999; Rai et al., 2006) has similar consequences. Multiple
factors contribute to this lethality, including aberrant gene expression,
genomic instability, and activation of cell cycle checkpoints and
apoptosis (Chen et al., 2007; Jackson-Grusby et al., 2001; Stancheva
et al., 2001; Unterberger et al., 2006). However, the molecular
pathways connecting hypomethylation to cell death, as well as the
relative importance of the catalytic and regulatory activities of
Dnmt1, remain unclear.
Here, we analyze zebraﬁsh dnmt1 mutants that were identiﬁed in
genetic screens for regulators of endodermal organ formation and
differentiation. Previous investigations of the developmental role of
dnmt1 in zebraﬁsh using a morpholino knockdown approach showed
decreased levels of differentiated cell types in the exocrine pancreas
and gut, while the endocrine cells of the primary islet remained intact
(Rai et al., 2006). In contrast, dnmt1 mutants develop normally until
84 hpf when highly proliferative endodermal organs undergo a
massive wave of apoptosis. These dnmt1 mutants retain the Dnmt1
regulatory domain, but are likely to be catalytically null, allowing
speciﬁc interrogation of the role played by Dnmt1-mediated methyla-
tion during the growth, differentiation, and regeneration of the
vertebrate pancreas.
Results
Endodermal organ degeneration in dandelion (ddn) mutants
The suitability of zebraﬁsh for embryological studies and muta-
genesis screens has fostered its emergence as a powerful genetic
system for studying vertebrate organ formation at high resolution.
Importantly, major genetic cascades regulating pancreas formation
appear to be conserved between zebraﬁsh and mammalian species
(Biemar et al., 2001; Delporte et al., 2008; Huang et al., 2001; Sun and
Hopkins, 2001; Yee et al., 2001; Zecchin et al., 2004), as are major
morphogenetic events (Field et al., 2003a). Brieﬂy, in zebraﬁsh, pdx1-
expressing pancreatic progenitors evaginate from the primitive
endodermal rod by 24 h post fertilization (hpf), forming the dorsal
pancreatic bud (Field et al., 2003b). Subsequently, a ventral bud
emerges from the ventral intestine and encapsulates the dorsal bud by
52 hpf, establishing the mature pancreatic architecture (Field et al.,
2003a). The dorsal bud is thought to give rise exclusively to the main
cluster of endocrine cells, the primary islet (Field et al., 2003a). In
contrast, the ventral bud generates the exocrine pancreas (acinar and
duct cells), although it also contributes endocrine cells via progenitors
in the pancreatic ducts (Dong et al., 2007; Field et al., 2003a).
To identify novel regulators of pancreas morphogenesis and
cytodifferentiation, we completed two ethylnitrosourea genetic
screens. The ﬁrst (Ober et al., 2006) was conducted using the Tg
(XlEef1a1:GFP)s854 (aka gut:GFP) line, which expresses GFP through-
out the endoderm, illuminating the morphogenesis of digestive
organs (Field et al., 2003b). The second was conducted using the Tg
(ins:dsRed)m1081;Tg(fabp10:dsRed;ela3l:GFP)gz12 (Farooq et al., 2008)
line which we refer to as 2CLIP (2-Color Liver Insulin acinar Pancreas)
for simplicity. This transgenic combination of red ﬂuorescence in
pancreatic beta cells and hepatocytes, and green ﬂuorescence in
pancreatic acinar cells permitted assessment of pancreas and liver
cytodifferentiation. Two phenotypically indistinguishable mutantswere recovered from the screens, s872 and s904, andwere determined
to be allelic by complementation test (27% mutant, n=272). The
mutant phenotype was fully penetrant, and exhibited little variation.
At 100 hpf, the mutants display a markedly smaller exocrine
pancreas, a smaller liver, smaller eyes, and dysmorphic branchial
arches (Figs. 1A–C and data not shown). Mutant larvae generally die
at 8 dpf. We examined individual wild-type (WT) and mutant
animals from fertilization to 148 hpf, and found that they were
indistinguishable until 84 hpf, at which point the amount of Tg
(ptf1a:GFP)jh1-expressing acinar tissue (Godinho et al., 2007)
progressively diminished (Figs. 1D, E). Early steps of liver differ-
entiation and morphogenesis also appeared to be unaffected, as
indicated by expression at 100 hpf of Tg(fabp10:dsRed)gz12 (nN100)
and immunostaining for Prox1 (pan-hepatic marker) and Alcam
(intrahepatic biliary network marker; (Sakaguchi et al., 2008); n=3)
although the overall liver mass was reduced (Figs. 2A, C, E, F). In
addition, in all ddn mutants, Tg(fabp10:dsRed)gz12-expressing cell
fragments and/or aggregates, could be observed throughout the
vasculature, most often accumulating in the caudal vein network
(Figs. 2B, D, G–J). In these fragments, dsRed ﬂuorescence did not co-
localize with DNA/nuclei (data not shown). In addition, fabp10 and
ceruloplasmin mRNAs, normally present in differentiated hepato-
cytes, were not detected in these clusters (data not shown). These
results suggest that the ectopic ﬂuorescence results from persistence
of dsRed protein in fragments of dead hepatocytes (perhaps
engulfed by macrophages), rather than from live, ectopic hepato-
cytes. To reﬂect this phenotype—the rapid growth and subsequent
dispersal/death of endodermal tissues—we named this mutant
dandelion (ddn).
Formation of the endocrine pancreas and ductal system
After the loss of most pancreatic acinar cells in ddn mutants, an
apparently WT cluster of beta cells consistently remained in the
primary islet (Figs. 1B, C). Therefore, the composition and architecture
of the islet was examined using immunostaining for the pan-
endocrine transcription factor Islet-1 (n=3), and the delta and
alpha cell hormones Somatostatin (n=2), and Glucagon (n=6),
respectively. At 100 hpf, we found that ddn mutants retained the WT
complement and arrangement of endocrine cells: a core of beta cells
surrounded by a mantle of alpha and delta cells (Figs. 1F–K). However,
we often observed small clusters of endocrine cells outside of the islet
(n=5; arrowheads, Figs. 1G, I, M), suggesting the generation of
endocrine cells from the ventral pancreatic bud as inWT, but impaired
migration/morphogenesis due to the deterioration of pancreatic
acinar tissue. To further investigate which tissues degenerate in ddn
mutants, we examined the formation of the pancreatic ducts. By Tg
(gut:GFP)s854 expression, the extra-pancreatic duct and gall bladder
appeared to be intact in ddn mutants at 100 hpf (Fig. 1G, n=3). We
also examined Nkx6.1 distribution, which normally marks intra-
pancreatic ducts at 100 hpf (Fig. 1K, n=3). Nkx6.1 expression was
maintained in ddn mutants, but at lower levels than in WT, which
indicated the persistence of disorganized duct cells. Altogether,
these data show that the ddn mutation differentially affects the cell
types that comprise the pancreas, with the acinar cells being the
most sensitive.
dandelion mutants lack Dnmt1 catalytic activity
To elucidate the developmental mechanisms responsible for this
phenotype, we isolated the gene affected by the ddn mutations. ddn
was genetically mapped to a 1.2 cM interval on chromosome three,
which contains six genes (Fig. 3A). Sequencing of these candidates
revealed mutations only in dnmt1. In s872, a missense mutation
caused a G1459D substitution in the DNA methyltransferase motif X
(Figs. 3B, D). This residue lies within the S-adenosyl L-methionine
Fig. 1. Initial formation and degeneration of the exocrine pancreas in dandelion (ddn)mutants. (A–C) Lateral views of WT (A), ddns872 (B), and ddns904mutant (C) larvae at 100 hpf in
the 2-color Liver, Insulin, acinar Pancreas (2CLIP) transgenic background (see Materials and methods). Acinar cells of the exocrine pancreas (xp) are green and hepatocytes (li) and
pancreatic beta cells (b) are red. ddnmutants exhibit minimal acinar tissue, but overall larva morphology is only moderately affected. (D, E) Successive images of individual WT (D)
and ddns872mutant (E) larvae between 84 and 148 hpf in the 2CLIP; Tg(ptf1a:EGFP)jh1 background. The exocrine pancreas and liver grow larger inWT, but degenerate in ddnmutants.
Hepatocyte fragments are found in the circulation (arrowheads). (F–K) 3-D projections of confocal stacks showing composition of WT (F, H, J) and ddns872mutant (G, I, K) endocrine
pancreas at 100 hpf in Tg(ins:dsRed)m1081 background. (F, G) A core of Tg(ins:dsRed)m1081+ cells (red) is surrounded by a mantle of Glucagon+ (Gcg) cells (green). Extrapancreatic
duct (epd) structure is intact. (H, I) Isl-1, and (J, K) Somatostatin (Sst) positive cells appear unaffected. Arrowheads in G, I, and M point to endocrine cells outside of the primary islet.
(L, M) Nkx6.1 immunostaining reveals the presence of intra-pancreatic duct cells in both WT and dnmt1s872 mutant larvae.
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bacterial methyltransferases (reviewed by Goll and Bestor (2005)).
Importantly, AdoMet is the methyl donor, and its binding to Dnmt1 is
essential for cytosine methylation; thus, this mutation likely abolishes
the catalytic activity of Dnmt1 without affecting other functional
domains. In s904, an exon 15 splice acceptor mutation causes a 1-bp
frameshift (Fig. 3C). This frameshift is predicted to truncate Dnmt1 at
Arg476, after appending 31 missense residues; thus, in s904 mutants,
Dnmt1 lacks the entire catalytic domain as well as the CXXC, BAH1,
and BAH2 domains (Fig. 3E).
To test methyltransferase activity in dnmt1mutants, we character-
ized global DNA methylation using methylation-sensitive DNA
restriction analysis. Southern blotting of HpaII-digested genomic
DNA with a probe for DANA, a short interspersed nuclear element
(SINE) that comprises ~10% of the zebraﬁsh genome (Izsvak et al.,
1996), revealed hypomethylation of this transposon sequence in
dnmt1s872 and dnmt1s904 mutants (Fig. 3F). In addition, using an
antibody generated against the Dnmt1 catalytic domain, we examined
the distribution of Dnmt1 in endodermal organs at 84 hpf, when
pancreatic degeneration begins. In WT larvae, Dnmt1 was observed in
the exocrine pancreas, liver, and intestine (Fig. 3G; nN10). Dnmt1 was
also detectable in s872 mutants (n=3), indicating that the mutant
form of the protein is not degraded (Fig. 3H). Dnmt1 was not
detectable inmost endodermal cells in s904mutants (n=8), althoughwe consistently observed a few weakly labeled cells scattered
throughout the endodermal organs. Altogether, these data imply
that the indistinguishable phenotypes of the dnmt1s872 and dnmt1s904
mutants result from a lack of methyltransferase activity.
Finally, we inhibited production of Dnmt1 using a morpholino
(d1MO) that targets the translation start site (Rai et al., 2006).
Injection of 4 ng of d1MO recapitulated the previously reported
phenotype: small eyes, small pharyngeal arches, and ventral body
curvature (Rai et al., 2006). More speciﬁcally, d1MO injection reduced,
but did not eliminate the mass of hepatocytes, acinar cells, and
pancreatic duct cells, as assessed in the 2CLIP (n=8), and Tg
(-3.5nkx2.2a:GFP)ia3 (n=6; (Pauls et al., 2007)) backgrounds (Figs.
3J, K and data not shown). In addition, d1MO injections had no effect
on the early wave of beta cell production, as previously reported ((Rai
et al., 2006); data not shown). The similarity of phenotypes in d1MO-
injected embryos and dnmt1s872 and dnmt1s904 mutants supports the
assertion that loss of Dnmt1 function in thesemutants andmorphants
results in defects in endodermal organ growth/maintenance.
Lack of methyltransferase activity results in apoptosis
The loss of pancreatic acinar cell markers in dnmt1 mutants could
be due to cell dedifferentiation, cell death, or both. To assess the extent
of each, we ﬁrst examined the expression of sox17, a transcription
Fig. 2. Liver degeneration in dandelion (ddn) mutants. (A–D) Lateral aspect of trunk (A, C) and tail (B, D) regions of 100 hpf WT (A, B) and ddn mutant (C, D) larvae in the 2CLIP
transgenic background. The liver is smaller in ddnmutants relative to WT, and cell fragments emitting dsRed ﬂuorescence, derived from the liver, aggregate in clusters in the tail (D,
arrows). (E, F) 3-D projections of confocal stacks showing Alcam and Prox1 antibody staining of 100 hpf WT (E) and ddn mutants (F). Initial speciﬁcation, morphogenesis, and
differentiation of the liver appear to be unaffected. Intrahepatic ductal network is indicated by arrows. (G–J) Confocal slices through the liver (G, I) and tail vasculature (H, J) of Tg
(kdrl:GFP)s843; Tg(fabp10:dsRed)gz12 WT (G, H) and ddnmutant (I, J) larvae at 6 dpf. Although never present in WT, bright dsRed+ degenerating hepatocyte fragments are observed
throughout the ddnmutant liver (I, arrows) and within the hepatic vasculature (I, arrowheads). These particles accumulate in the network of the caudal vein (cv; J, arrows). Other
abbreviations: ca, caudal aorta; se, intersegmental vessel; ib, intestinal bulb; p, pancreas; li, liver; b, beta cells.
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in differentiated pancreatic tissue. Since silencing of the SOX17
promoter in cancer cell lines is associated with its CpG island
hypermethylation (Zhang et al., 2008), we hypothesized that re-
expression of sox17 would indicate a reversion to a more primitive
identity. However, we did not detect sox17 expression in the pancreas
of dnmt1 mutants at 84 or 100 hpf (n=10). Next, since repression of
transposon activity is one of the major characterized functions of
cytosine methylation, we investigated the expression of the repetitive
SINE element DANA. While DANA sequences were hypomethylated in
dnmt1 mutants (see above), we did not detect ectopic expression of
the DANA sequence by in situ hybridization (n=12).
In dnmt1 mutants, but not WT, we frequently observed pyknotic
nuclei throughout the pancreas during degeneration (Figs. 4A, B),
suggesting cell loss via death. To determine whether this phenotype
was caused by programmed cell death, we performed TUNEL assays.
In 84 hpf WT embryos, virtually no TUNEL+ cells were observed in Tg
(ptf1a:GFP)+ acinar tissue, while more than 12% of acinar cells were
labeled in dnmt1mutants (Figs. 4C–E). In addition, widespread TUNEL
labeling was observed in the mutant liver and intestine, which in WT
exhibit essentially no apoptosis at this stage (data not shown).
To determine whether the observed apoptosis could be p53-
dependent, we examined the expression of p53 by in situ hybridiza-
tion. In 84 hpf dnmt1 mutants, clear up-regulation of p53 expression
was apparent in affected tissues, including pancreas, liver, intestine,
branchial arches, and eyes (Figs. 4F–I). We conﬁrmed this result using
real-time RT-PCR, which showed up-regulation of p53 and its targets
mdm2 and p21/waf1 (Fig. 4J). To test the signiﬁcance of p53 up-
regulation, we inhibited production of P53 using an antisense splice
morpholino (p53MO) (Chen et al., 2005). At 108 hpf, we observed a
considerable rescue of exocrine pancreas morphology in 82% of
p53MO-injected dnmt1 mutants (37/45, pb0.0002) as compared to
uninjected dnmt1mutants (1/22; Figs. 4K–O). This result suggests that
in dnmt1 mutants, hypomethylation is sensed as DNA damage, which
results in some p53-dependent apoptosis. While we cannot rule out anincomplete knockdown of P53 following p53MO injection, the incom-
plete suppression of the degeneration phenotype suggests that some
cell death in dnmt1 mutants is mediated by a p53-independent
response. Other mutant phenotypes, including small liver, circulating
hepatocyte fragments, and small eyes, which become apparent later
than the exocrine pancreas phenotype, were notmeasurably rescued by
p53MO injections, perhaps due to depletion of the morpholino.
The depletion of Dnmt1 in cultured cells causes inhibition of
replication origin initiation and intra-S-phase arrest (Knox et al.,
2000; Milutinovic et al., 2004) via activation of Chk1, Chk2, and ATR
checkpoint kinases (Unterberger et al., 2006); prolonged arrest at cell
cycle checkpoints may initiate apoptotic pathways. To determine
whether dnmt1 mutant acinar cells arrest during S-phase, we
examined the incorporation of the thymidine analog EdU as a
measure of DNA synthesis (Figs. 5A, B). We observed no signiﬁcant
changes in the number of labeled pancreatic acinar cells between WT
and dnmt1 mutants at 84 hpf (p=0.87; Fig. 5E). We also examined
the EdU incorporation rate in other highly proliferative endodermal
tissues. The rate of labeling also appeared to be unaffected in liver
(p=0.52) and intestine (p=0.91; Fig. 5E). Next, to determine
whether acinar cells were blocked at the G2/M checkpoint, we used
phosphorylated histone H3 (PH3) to mark cells in late G2 through M
phase (Figs. 5C, D). Again, we observed no signiﬁcant difference in the
number of PH3+ cells between WT and dnmt1 mutants at 84 hpf (44
sections from 4 WT embryos, 46 sections from 4 s904 mutants,
p=0.73). Finally, we tested whether inhibition of checkpoint kinases
could rescue the degeneration phenotype, and therefore reveal
whether activation of checkpoints was involved. WT and dnmt1
mutant embryos were treated with SB 203580 (p38 MAP kinase
inhibitor; (Takenaka et al., 1998)) or 2-Morpholin-4-yl-6-thianthren-
1-yl-pyran-4-one (ATM inhibitor; (Hickson et al., 2004)) from 48 to
108 hpf. Neither of these treatments affected the degeneration of the
exocrine pancreas (data not shown; nN25 dnmt1s872 mutants).
Together, these results suggest that loss of Dnmt1 catalytic activity
per se does not prohibit DNA replication or entry into mitosis, and
Fig. 3. The dandelion phenotype is caused by mutations in dnmt1. (A) Genetic map of the ddn region on linkage group 3; the numbers above the SSLP/RFLP markers indicate the
number of recombinants in 932 meioses analyzed. Six genes lie within the critical region (shaded). (B) Sequence traces of pooled phenotypically WT and pooled dnmt1s872 mutant
cDNAs; a G to A transversion at nucleotide 4376 results in a G1459D substitution in Dnmt1. (C) Sequence traces of pooled phenotypically WT and pooled dnmt1s904 mutant genomic
DNA; a mutation in the exon 15 splice acceptor results in a single base pair frameshift and premature termination following 31 missense substitutions. (D) Peptide sequence
alignment of D. rerio (Dr) Dnmt1 from dnmt1s872mutant andWT with H. sapiens (Hs),M. musculus (Mm), X. laevis (Xl), and A. thaliana (At). (E) Domain map of WT and ddn alleles of
Dnmt1. (F) Southern blot of WT and dnmt1s872 and dnmt1s904 mutant genomic DNA either uncut or digested with methylation-sensitive HpaII or methylation insensitive MspI, and
hybridized with a radiolabeled probe to the DANA consensus sequence. Appearance of DANA band (arrow) in dnmt1 mutant DNA digested with HpaII indicates hypomethylation of
this transposable element, while smearing of high molecular weight DNA indicates widespread genomic hypomethylation (compare bracketed regions). (G–I) Dnmt1 antibody
staining in 2CLIP transgenic line. Dnmt1 (blue) is observed in endodermal organs of WT (G) and dnmt1s872 mutants (H), but not dnmt1s904 mutants (I). (J–L) Injection of 4 ng of
dnmt1morpholino (d1MO) into the 2CLIP line phenocopies ddnmutants. Compared to WT (J), d1MO-injected larvae (K) show smaller mass of differentiated pancreatic acinar cells
(green) and hepatocytes (red) at 96 hpf. Ectopic dsRed ﬂuorescence is observed in the posterior vasculature of d1MO-injected larvae at 168 hpf (L).
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at cell cycle checkpoints.
Since Dnmt1 is targeted to the replication fork during S-phase, we
reasoned that the different responses of acinar and endocrine cells to
the loss of Dnmt1 catalytic activity might be based on differences in
proliferation rates between these two populations. In other words, if
DNA is passively demethylated during replication in the absence of
Dnmt1, then cells which have dividedmore frequently should bemore
affected. InWTembryos, endocrine cells in the primary islet are rarely
labeled with EdU, indicating a very low proliferation rate (dashed
circle, Fig. 5A). In contrast, the acinar cells are generated from the
ventral pancreatic bud, which grows dramatically between 34 and
84 hpf, and exhibits a high level of proliferation (Fig. 5A). We devised
an H2BRFP label retention assay to examine the cumulative
proliferative histories of pancreatic cells. We presumed that H2BRFP
would behave similarly to H2BGFP, a stable fusion protein that is
localized to chromatin (Megason and Fraser, 2003); because of its
stability, the intensity of nuclear ﬂuorescence is diminished over time
primarily by its stoichiometric dilution via cell division (Brennand
et al., 2007). As such, ﬂuorescent signal should be retained in non-
proliferating cells and lost in highly proliferative cells. H2BRFP mRNA
was injected into one-cell stage embryos, leading to uniform labeling
through 24 hpf. By 52 hpf, after the fusion of the dorsal and ventralpancreatic buds, clear differences in ﬂuorescence intensity were
observed between the two buds (Fig. 5F), with the dorsal bud
showing strong ﬂuorescence and the ventral bud showing weaker
ﬂuorescence; this difference was more pronounced at 84 hpf after
the outgrowth of the pancreatic tail (Fig. 5G). These data show that
pancreatic cells originating from the dorsal and ventral buds have
vastly different proliferative histories. Furthermore, since dnmt1
mRNA is maternally provided in zebraﬁsh (Martin et al., 1999;
Mhanni and McGowan, 2002), these results suggest that the dorsal
bud-derived endocrine cells in the primary islet are not affected in
dnmt1 mutants because they are formed by 24 hpf, when maternal
messages or proteins may still be present in the embryo. Moreover,
these islet cells are largely quiescent and may not require Dnmt1
after their differentiation.
Regeneration of beta cells in dnmt1 mutants and morphants
The highly proliferative ventral pancreatic bud generates all three
types of pancreatic tissue: acinar, duct, and endocrine. Intriguingly,
our data show that acinar cells are more severely affected by the loss
of Dnmt1 catalytic activity than are endocrine or duct cells. Indeed, the
organization of the primary islet remains unaffected in dnmt1
mutants: a core of beta cells surrounded by a mantle of alpha cells
Fig. 4. Acinar cell death in dnmt1 mutants occurs in part by p53-dependent apoptosis. (A, B) DRAQ5 staining of DNA in 84 hpf WT (A) and dnmt1s872 mutant (B) larvae. Pyknotic
nuclei (arrows) are frequently observed in the pancreas of dnmt1mutants, but notWT. (C, D) Apoptosis detection by TUNEL labeling of 84 hpfWT (C) and dnmt1mutant (D) larvae in
Tg(ptf1a:EGFP)jh1; Tg(ins:dsRed)m1081 background. C'/Cq and D'/Dq are transverse sections of similar samples at the approximate planes indicated in panels C and D, respectively. (E)
Quantiﬁcation of TUNEL+ acinar cells. (F–I) Expression of p53 mRNA in WT (F, H) and dnmt1s872 mutants (G, I); expression appears dramatically increased in mutants. (J) Fold-
change of p53 and target genesmdm2 and p21/waf1 in dnmt1s872mutants vs. WT by real-time RT-PCR. (K–N) 100 hpfWT (K, L) and dnmt1s872mutant (M, N) larvae, which are either
uninjected controls (K, M) or p53morpholino-injected (p53MO; L, N). p53MO-injected dnmt1s872mutants show increased persistence of acinar tissue. (O) More than 82% of p53MO-
injected dnmt1s872 mutants showed rescue (green); n=22 (control), n=45 (p53MO). Error bars=SEM. Signiﬁcance assessed by Student's t-test.
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in the later development of endocrine cells from progenitors, we
examined beta cell neogenesis in dnmt1mutants during regeneration
of the primary islet. In WT larval zebraﬁsh pancreas, we and others
have shown that the beta cell mass has the capacity to recover
following targeted ablation (Curado et al., 2007; Pisharath et al.,
2007). Using this strategy, we ablated beta cells in WT and dnmt1
mutants using a nitroreductase transgene (Tg(ins:CFP-NTR)s892)
together with metronidazole (MTZ) exposure from 96–120 hpf,
followed by a recovery period in the absence of MTZ for 48 h
(Fig. 6A). The ablated WT islets exhibited recovery of beta cells
during the washout period (7.6 Ins+ cells/islet, n=7; Fig. 6D).
Remarkably, we observed a signiﬁcantly greater number of beta cells
generated de novo in recovering dnmt1 mutant larvae (14.6 Ins+
cells/islet, n=9, p=0.014; Fig. 6F). Many of the newly produced
beta cells in recovering dnmt1 mutants were morphologically
abnormal possibly due to the deteriorating health of 7 dpf dnmt1
mutants, which die around 8 dpf. Therefore,we depleted Dnmt1 inWT
embryos using d1MO. With injection of 4 ng, we observed the reported
phenotype: small endodermal organs, small eyes, and curvedbodyaxis
(see above anddata not shown; (Rai et al., 2006). However, injection of
2 ng of d1MO did not have an overt effect. We reasoned that a
moderate, and likely temporary, reduction in Dnmt1 would result in
modest changes in cytosine methylation, and might inﬂuence
regeneration of beta cells from progenitors. Thus, we injected 2 ng ofd1MO into one-cell stage Tg(ins:CFP-NTR)s892;Tg(-4.0ins:GFP)zf5
embryos, and then treated them with MTZ from 84–108 hpf to ablate
beta cells. After MTZ washout and a 24 h recovery period, beta cells
were counted (Fig. 6G). In WT, we observed an average of 6.7 new
cells per pancreas (Fig. 6J, n=6), while in morphants, an average of
10.8 cells were observed (Fig. 6K, n=9, p=0.008). Importantly, in
dnmt1 morphants, the morphology of the new beta cells appeared
WT-like.
Discussion
In this paper, we report the identiﬁcation of two mutations in the
gene encoding themaintenancemethyltransferase Dnmt1 that disrupt
its catalytic activity. We have used these new reagents to speciﬁcally
investigate the roles of DNA methylation by Dnmt1 during pancreatic
development. Our data reveal two novel developmental roles for
cytosine methylation in the formation of the pancreas: the survival of
differentiated acinar cells, and control of de novo beta cell formation.
The pancreas is comprised of three major endodermal cell types,
endocrine, duct, and acinar cells, that are differentially affected in
dnmt1 mutants. The formation of endocrine and duct cells is largely
unaffected, while acinar cell survival is severely compromised, with
the majority of cells degenerating by 100 hpf. Because dnmt1 is
supplied maternally (Martin et al., 1999; Mhanni and McGowan,
2002), it is possible that these differential effects reﬂect different
Fig. 5. Lack of Dnmt1 activity does not arrest the cell cycle. (A, B) Confocal planes showing EdU incorporation in 84 hpf WT (A) and dnmt1 mutant (B) Tg(ptf1a:EGFP)jh1;
Tg(ins:dsRed)m1081 larvae. (C, D) Phospho-histone 3 (late G2 interphase through anaphase marker) and Dnmt1 staining of 84 hpf WT and dnmt1s904 mutant Tg(fabp10:DsRed;
ela:GFP)gz12 larvae. (C', D') Dnmt1 channel only. (E) EdU incorporation rate in pancreatic acinar cells, hepatocytes, and intestine of dnmt1mutants appears indistinguishable fromWT
(p=0.87, p=0.52, p=0.91, respectively). Error bars=SEM. Signiﬁcance assessed by Student's t-test. (F, G) H2BRFP label retention analysis of endodermal organ forming region in
WT Tg(gut:GFP)s854 animals at 52 (F) and 84 (G) hpf. The ventral pancreatic bud (vpb) is demarcated by a dashed line. H2BRFP is diminished in the highly proliferative vpb relative to
the dorsal pancreatic bud during outgrowth (F) and pancreas tail formation (G). (F', G') H2BRFP (red) and Ins (blue) channels only. Primary islet (pi).
219R.M. Anderson et al. / Developmental Biology 334 (2009) 213–223proliferative histories of each tissue, and thus differential dilution of
maternal Dnmt1. Indeed, our label retention analysis shows that in the
highly proliferative ventral bud cells, H2BRFP is diluted much more
than the largely quiescent dorsal bud cells. This result suggests that
the endocrine cells, which predominantly arise from the dorsal bud,
are spared either because they do not require dnmt1, or because
maternal dnmt1 contribution is retained in these cells. Since the
degenerating tissues in dnmt1 mutants (pancreatic acinar cells,
hepatocytes, eye, branchial arches) exhibit high proliferation rates,
these ﬁndings strongly suggest that Dnmt1 is required for the survival
of highly proliferative cell types. However, the ventral bud also
contributes a portion of endocrine cells and all duct cells, and these
appear largely unaffected in dnmt1mutants. Thus, in the pancreas, the
requirement for dnmt1 may be speciﬁc to proliferating acinar cells,
rather than all ventral bud derivatives.
Our results expand upon those of Rai et al. (2006) who showed
that knockdown of Dnmt1 with translation-inhibitingMOs resulted in
reduced acinar cell mass, as measured by reduced trypsin expression.
In our hands dnmt1-MO injections did not eliminate the differentia-
tion of acinar cells, beta cells, or pancreatic ducts. Rather, dnmt1-MO
injections reduced the mass of the ventral pancreatic bud-derived
tissues with no effect on the early wave of beta cell production from
the dorsal pancreatic bud. Since dnmt1 is maternally and zygotically
contributed, it is likely that Dnmt1 protein is present during some
stages of ventral pancreas growth and differentiation in both dnmt1
mutants, and dnmt1 morphants. Nonetheless, our ﬁndings and thoseof Rai et al. (2006) are consistent with a model in which Dnmt1
activity may not be absolutely required for the differentiation of
pancreatic acinar cells, but rather for their proliferative expansion.
Since cytosine methylation is inversely correlated with gene
expression, we examined dnmt1 mutants for reactivation of the
primitive endodermal marker sox17 in the pancreas, and expression of
the SINE element DANA. Expression of neither gene was signiﬁcantly
altered at either 84 or 100 hpf. Thus, although deletion of Dnmt1 in
cultured mouse ﬁbroblasts resulted in increased transcription of up to
10% of detectably expressed genes (Jackson-Grusby et al., 2001), and
loss of dnmt1 in ddnmutants can reactivate the expression of silenced
transgenes (Goll et al., 2009), our limited survey argues against a
major role for large-scale mis-regulation of gene expression in causing
the pancreatic acinar tissue degeneration in dnmt1 mutants.
Initiation of apoptosis results from a wide variety of cellular
stresses, including DNA damage and aberrant activation of oncogenes,
and is often mediated by the tumor suppressor p53. Moreover, prior
studies indicate that apoptosis may be inﬂuenced by the concerted
action of Dnmt1 and p53; for instance, loss of Dnmt1 catalytic activity
in mouse ES cells results in phosphorylation of p53 (Takebayashi et al.,
2007), and loss of Dnmt1 function in cultured mouse ﬁbroblasts
causes apoptosis that is largely rescued by p53 inactivation (Jackson-
Grusby et al., 2001). We foundmoderately increased survival of acinar
cells in dnmt1 mutants when we reduced p53 levels using an
antisense morpholino, but not a complete rescue. Thus, it is possible
that p53-independent apoptotic pathways are also initiated, although
Fig. 6. Enhanced recovery of beta cell mass in dnmt1 mutants and morphants. (A) Pancreatic beta cell ablation scheme in dnmt1s872 mutants. 96 hpf Tg(ins:CFP-NTR)s892 WT and
dnmt1mutant larvae were exposed to MTZ for 24 h , thenwashed for 48 h and analyzed at 168 hpf. (B–E) Three-dimensional projections of the primary islet at 168 dpf in WT (B, D)
and dnmt1mutant (C, E) larvae thatwere untreated (B, C), or ablatedwithMTZ (D, E). (B, C)WTand dnmt1mutant islets have a core of Ins+beta cells surrounded byamantle of Gcg+
alpha cells. (D) In recoveringWT larvae, newbeta cells are observed in the islet (arrow). (E) In recoveringdnmt1mutant islets, nearly double the number of beta cells is present, though
some appearmorphologically abnormal (arrows; comparewith panel D). (F) 7.6±1.0 beta cells were observed in recoveringWT islets (n=7), and 14.6±2.0 beta cells were observed
in recovering dnmt1mutant larvae (n=9; p=0.014). (G) Pancreatic beta cell ablation scheme in Tg(ins:CFP-NTR)s892 embryos injected with 2 ng of dnmt1morpholino (dnmt1-MO).
84 hpf larvaewere exposed toMTZ for 24 h , thenwashed for 24 h and analysed at 132 hpf. (H–K) Three-dimensional projections of the primary islet at 132 hpf inWT (H, J) and dnmt1-
MO injected (I, K) larvae thatwere untreated (H, I), or ablatedwithMTZ (J, K). (K) dnmt1-MO injected larvae showed a greater degree of beta cell recovery. (L) 6.5±0.5 beta cells were
observed in recoveringWT larvae (n=15), and 9.5±0.6 beta cells were observed in recovering dnmt1-MO injected larvae (n=22; p=0.002). Error bars=SEM. Signiﬁcance assessed
by Student's t-test.
220 R.M. Anderson et al. / Developmental Biology 334 (2009) 213–223it is also possible that the p53 levels were not sufﬁciently reduced, or
were recovering at later stages of development as the morpholino was
diluted with cell division.
When DNMT1 is inactivated in HCT116 cancer cells, a transient
arrest at the G2/M cell cycle checkpoint is enacted then resolved,
resulting in dramatic chromosomal aberrations, mitotic catastrophe,
and cell death (Chen et al., 2007). This observation prompted
speculation that Dnmt1 may have multiple roles which are progres-
sively uncovered by reduction of Dnmt1 protein levels (Brown and
Robertson, 2007). The canonical role of Dnmt1 is revealed by
moderate reduction of protein levels, such as is found in hypomorphs
and partial knockdowns, leading to phenotypes such as DNA
hypomethylation, genomic instability, and decreased replicationpotential. In contrast, the total depletion of Dnmt1 reveals non-
canonical roles that manifest as massive DNA damage and chromo-
somal instability. For instance, Dnmt1 associates with peri-
centromeric heterochromatin DNAduringG2 andMphases, indicating
a post-DNA replication function in centromeremethylation (Easwaran
et al., 2004). Methylation inﬂuences kinetochore assembly at cen-
tromeres (Mitchell et al., 1996), and demethylation causes chromatin
remodeling at pericentric regions (Ma et al., 2005). Thus, cytosine
methylation plays many roles in maintaining the integrity of the
genome and the structure of chromosomes. Since zebraﬁsh dnmt1
mutants lack functional zygotic Dnmt1, but are initially endowed with
a maternal supply, the functional complement of Dnmt1 is diminished
with each cell division. It is likely that such “non-canonical” roles of
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populations, such as the pancreatic acinar cells, and might result in
genomic damage during cell division. The induction of p53, its target
genesmdm2 and p21/waf1, and apoptosis are typical cellular responses
to DNA damage. Their striking induction in dnmt1 mutants suggests
that loss of Dnmt1 catalytic activity results in genomic changes that
may be sensed as DNA damage.
The increased de novo beta cell neogenesis observed in dnmt1
mutants and morphants after beta cell ablation suggests that
surviving pancreatic cells have an increased capacity to differentiate
into beta cells. There is burgeoning evidence that regulation of
genomic methylation patterns can be manipulated to control the
reprogramming of cells and alter their potency. For instance,
reprogramming of promoter methylation at pluripotency genes may
be a key mechanism by which epigenetic regulation of pluripotency is
effected (Farthing et al., 2008; Mikkelsen et al., 2008). Also, the
methylation status of donor nuclei can strongly inﬂuence the
efﬁciency of deriving totipotent ES cell lines by nuclear transfer
from differentiated cells (Blelloch et al., 2006). Furthermore, inhibi-
tion of Dnmt1 activity with 5-aza-2'-deoxycytidine may facilitate the
reprogramming of mouse embryonic ﬁbroblasts into pluripotent stem
cells (Huangfu et al., 2008). Our data suggest that genomic
hypomethylation caused by disrupted Dnmt1 activity is correlated
with a greater capability to form de novo beta cells in response to
ablation. Further studies are needed to determine the biological
mechanism of this enhanced ability, as well as the source of the new
beta cells. Increased beta cell regeneration in Dnmt1-depleted
zebraﬁsh may result from reprogramming of terminally differentiated
pancreatic cells, the facilitation of beta cell production from multi-
potent progenitors, or simply an increased capacity for endocrine cell
differentiation in the absence of exocrine tissue. Our ﬁndings could
have implications for the therapeutic regeneration of beta cells, if
coaxing of endogenous lineage-committed progenitor cells as well as
terminally differentiated cells into new fates could be aided by
manipulation of DNA methylation levels either globally, or at speciﬁc
loci.
Materials and methods
Zebraﬁsh strains and lines
Zebraﬁshwere raised under standard laboratory conditions at 28 °C.
We used the following lines: dnmt1s872, dnmt1s904, Tg(ins:CFP-NTR)s892
(Curado et al., 2007), Tg(XlEef1a1:GFP)s854 (Field et al., 2003b), Tg
(fabp10:dsRed, ela3l:GFP)gz12 (Farooq et al., 2008), Tg(ins:dsRed)m1081
(gift of W. Driever), Tg(-4.0ins:GFP)zf5 (Huang et al., 2001), Tg(kdrl:
EGFP)s843 (Beis et al., 2005), and Tg(ptf1a:EGFP)jh1 (Godinho et al.,
2007), and the WIK strain for mapping.
Genetic screening
Mutagenesis of Tg(XlEef1a1:GFP)s854 was previously described
(Ober et al., 2006; Shin et al., 2008). For the 2CLIP screen, 36 males
received six 1 h exposures to 3.5 mM ENU at weekly intervals. From
the number and extent of F2 families screened, we calculate that we
surveyed 662 genomes.
Genetic mapping
Wemapped the ddns872mutation to chromosome 3 using standard
SSLP markers. For ﬁne mapping, 466 mutant embryos were tested
with SSLP markers in the critical region. We isolated, sequenced, and
analyzed dnmt1 cDNA from WT, and mutant embryos. Additionally,
genomic DNA was isolated and sequenced from WT and s904 mutant
embryos to conﬁrm the splice acceptor mutation.Methylation analyses
At 7 dpf, larvae were sorted as WT or dnmt1s872 based on
phenotype. Genomic DNA was isolated from pools of 10 phenotypi-
cally WT or mutant larvae. DNA (100 ng) was digested with the
restriction enzyme MspI, HpaII or mock digested in buffer alone.
Following digestion, samples were electrophoresed through a 0.9%
agarose gel then transferred to a nylon membrane. Membranes were
probed with radiolabeled DANA sequence ampliﬁed from the genome
using primers 5′GGCGACRCAGTGGCGCAGTRGG and 5′TTTTCTTTTTG-
GCTTAGTCCC (Izsvak et al., 1996).
Immunoﬂuorescence
Antibody staining was performed as described (Shin et al., 2008)
using the following antibodies: Dnmt1 (Santa Cruz SC-20701), HNF4a
(Santa Cruz SC-6556), Islet-1, Nkx6.1, and Alcam (Developmental
Studies Hybridoma Bank 39.4D5, F55A10, and zn-8), Somatostatin
(Serotec 8330-0154), Glucagon (Sigma G2654), phospho-histone
(Abcam ab14955), and Caspase-3 (Cell Signaling 9661S).
mRNA expression
In situ hybridization was performed as described (Shin et al., 2007).
The DANA probe was based upon GenBank accession # L42295.1;
template was PCR ampliﬁed from cDNA using 5′GGTTA GTGGC GCAGT
GGGAA GT and 5′GGTTA TTTAG GTGTAC ACTAT AGTTA ATCCA GGGTC
ACCAC AG, and transcribed with SP6 polymerase. For real-time RT-PCR,
mRNAwas extracted from 20 pooled 5 dpf WT or s872mutant embryos
using Trizol (Invitrogen #15596018) and then reverse-transcribed using
a Superscript III kit (Invitrogen#11732020). Optimizedprimers targeting
each gene and β-actin were designed using the Plexor Primer Design
System (Promega): β-actin (5′GTGGT CTCGT GGATA CCGCA A and 5′
CTATGAGCTG CCTGACGGTC A); p53 (5′CACCATCAGC TTCTT TCCCTand
5′TAAGT GATGT GGTGC CTGCC); mdm2 (5′CCCTC ACTGC GAGATATACC
and 5′GAGGC ATAAG TCGGA CAGCT); and p21/waf1 (5′TAGAC GCTTC
TTGGC TTGGT and 5′ATCCC GAAAA CACCA GAACG). An aliquot of each
cDNA sample and the appropriate primers were added to Power SYBR
Green master mix (Applied Biosystems). The 7900HT Real-Time PCR
System (Applied Biosystems) was used to obtain Ct values. The relative
expression of each sample was determined after normalization to
β-actin using the relative standard curvemethod (Larionov et al., 2005).
Proliferation and apoptosis analyses
Click-IT (Invitrogen C10085) was adapted for S-phase labeling.
Larvae were injected pericardially with 5 nl of EdU (200 μM+2%
DMSO+0.1% phenol red), incubated 60min at 28 °C. Forwhole-mount
analysis, larvae were ﬁxed in 3% formaldehyde. Before detection,
samples were washed with PBS+ 0.3% Triton X-100+0.1% Tween-20
for 20 min. Greater than 5 optical sections at 4 μm intervals were
analyzed for each sample. For cell area measurements, and manual
counting of EdU or PH3+ cells, images were analyzed with ImageJ
software. For EdU quantiﬁcation on frozen tissue sections, larvae were
ﬁxedwith 4% paraformaldehyde, embedded in OCTand sectioned at 10
microns. Liver and gut tissues were counterstained with HNF4a
antibody. Signiﬁcance was assessed with unpaired t-test. TUNEL was
performed as described (Curado et al., 2007). For H2BRFP labeling,
embryos were injected with 100 pg of H2BRFP mRNA (Megason and
Fraser, 2003).
Chemical inhibitors
Larvae were exposed to 10 μM of SB-203580 p38 inhibitor (A.G.
Scientiﬁc) or 2-Morpholin-4-yl-6-thianthren-1-yl-pyran-4-one ATM
inhibitor (Calbiochem) from 48–108 hpf.
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p53was knocked down using 8 ng of a previously described splice-
inhibiting morpholino (Chen et al., 2005), while dnmt1, was knocked
down using 2 or 4 ng of a previously described translation-inhibiting
morpholino (Rai et al., 2006).
Beta cell ablation and recovery
WT and dnmt1s872 mutant or dnmt1 morphant larvae bearing
Tg(ins:CFP-NTR)s892 were treated with metronidazole for 24 h as
described (Curado et al., 2008), followed by 24 or 48 h recovery.
The beta cell mass was visualized with Insulin staining. Statistical
signiﬁcance was assessed with unpaired t-test.
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